Addendum to previous post (needed to include the
per annum tag for relevant lines of the model)
The Finacial Model (after Year 2)
Target Population 750,000,000
Target rate @ 10% 75,000,000
Per annum
Margin on each test A$0.75
SBN revenue (membrane only) A56,250,000
Per annum
50% model discount A28,125,000
applied Per annum
SBN EBITDA A28,125,000
Per annum
Business multiple X20
(conservative for Biotech Cos) X10
Market Capitalisation A281,250,000
Number of shares (undiluted) 750,000,000
SP A$0.375
This model has a 50% dicount applied and ignores any potential revenue generated from the 15% equity which would include full retail price margins on the total product including the membrane.
Addendum to previous post (needed to include the per annum tag...
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)